California’s SB 1120: New Regulations on AI in Health Plan Utilization Review Starting January
Beginning January 1, California health care service plans and disability insurers will operate under new rules governing the use of…
Category: AI Policy & Regulation
Why Scrutinizing AI Vendor Security Is a Non-negotiable in Healthcare
Artificial intelligence is changing the face of healthcare, from diagnosing complex diseases to optimizing treatment plans and managing patient data.…
Understanding FDA’s Role in Regulating AI for Medical Products
New technologies are frequently hailed as transformative in healthcare, yet AI has exceeded even the loftiest expectations, emerging as a…
CMS Request Information on AI Technologies: A Call to Action for Health Innovators
The Centers for Medicare & Medicaid Services (CMS) plays a crucial role in the United States healthcare system, providing health…
Navigating the Future of Healthcare AI Policy: Insights from HAI Closed-Door Workshop
In May 2024, the Stanford Institute for Human-Centered AI (HAI) hosted a closed-door workshop attended by 55 influential figures from…
State-by-State AI Legislation Snapshot: Current Status and Future Proposals
As artificial intelligence (AI) continues to evolve and permeate various sectors, state legislatures across the United States are increasingly focusing…
What OCR’s HIPAA Guidance Updates Mean for AI Integration in Healthcare
The rapid advancement of technology has transformed many aspects of healthcare, with artificial intelligence (AI) emerging as a much-needed tool…
Understanding the Blueprint for an AI Bill of Rights: Implications for AI in Healthcare
As artificial intelligence (AI) technologies rapidly evolve and permeate various aspects of daily life, concerns about their implications for society…
FDA Unveils White Paper on AI Medical Device Regulation: Key Insights and Implications
On March 15, 2024, the U.S. Food and Drug Administration (FDA) published a white paper detailing its collaborative efforts to…
Understanding the FDA’s Strategy for Regulating AI in Medical Products
On March 15, 2024, the U.S. Food and Drug Administration (FDA) released a significant publication titled “Artificial Intelligence and Medical Products:…
The Evolving Regulatory Framework for AI in U.S. Healthcare: What You Need to Know
Unlike many countries that are implementing cohesive regulations for artificial intelligence (AI), the United States has chosen a more disjointed…
Addressing Bias in Healthcare AI: What Congress is Doing to Protect Patients
As artificial intelligence (AI) continues to integrate into healthcare, federal legislators are evaluating strategies to safeguard patients while encouraging innovation.…